TNM Classification of Malignant Tumours, 7th Edition
August 2011, Wiley-Blackwell
The major alterations addressed in the 7th Edition concern carcinomas of the oesophagus and the gastroesophageal junction, stomach, lung, appendix, biliary tract, skin, and prostate. In addition, there are several entirely new classifications:
- gastrointestinal carcinoids (neuroendocrine tumours)
- gastrointestinal stromal tumour
- upper aerodigestive mucosal melanoma
- Merkel cell carcinoma
- uterine sarcomas
- intrahepatic cholangiocarcinoma
- adrenal cortical carcinoma.
A new approach has also been adopted to separate anatomical stage groupings from prognostic groupings in which other prognostic factors are added to T, N, and M categories. These new prognostic groupings, as well as the traditional anatomical groupings, are presented for oesophageal and prostate carcinomas.
Visit www.wileyanduicc.com for more information about the International Journal of Cancer and our other UICC book titles
Organizations Associated with the
Members of UICC Committees Associated with the TNM System.
HEAD AND NECK TUMOURS.
Lip and Oral Cavity.
Nasal Cavity and Paranasal Sinuses.
Malignant Melanoma of Upper
Major Salivary Glands.
DIGESTIVE SYSTEM TUMOURS.
Oesophagus including Oesophagogastric Junction.
Gastrointestinal Stromal Tumour (GIST).
Appendix – Carcinoma.
Appendix – Carcinoid.
Gastric, Small & Large Intestinal Carcinoid Tumours.
Colon and Rectum.
Liver - Hepatocellular Carcinoma.
Intrahepatic Bile Ducts.
Extrahepatic Bile Ducts – Perihilar.
Ampulla of Vater.
LUNG AND PLEURAL TUMOURS.
BONE AND SOFT TISSUE TUMOURS.
Carcinoma of Skin.
Carcinoma of Skin of Eyelid.
Malignant Melanoma of Skin.
Merkel Cell Carcinoma of Skin.
Uterus – Endometrium.
Gestational Trophoblastic Tumours.
Renal Pelvis and Ureter.
ADRENAL CORTEX TUMOURS.
Carcinoma of Conjunctiva.
Malignant Melanoma of Conjunctiva.
Malignant Melanoma of Uvea.
Sarcoma of Orbit.
Carcinoma of Lacrimal Gland.
"This is an update of the standard manual that has proven its value over the many years since it was first published ... .The seventh edition will be welcomed by all who have used the previous editions." (Doody's, March 2010)
"The material is therefore immediately applicable to patients worldwide, and not influenced by any particular healthcare system. The publication's greatest virtue continues to be its simplicity, distilling and arranging complex data in a way that is immediately applicable wherever cancer patients are seen." (Knowledgespeak, December 2009)